Ana Chrystina de Souza Crippa

Ana Chrystina de Souza Crippa

Auto-generated profile, based on publicly available information

Ana Chrystina de Souza Crippa

Universidade Federal do Paraná, Hospital das Clínicas, Unidade de Neuropediatria, Curitiba PR, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Revista Paulista de Pediatria
Verified
Journal Article
Open access
GMGabriela Araujo Moreira
Gabriela Araujo Moreira
RNRoddie Moraes Neto
Roddie Moraes Neto
RRRicardo Gullit Ribeiro
Ricardo Gullit Ribeiro
ACAna Chrystina De Souza Crippa
Ana Chrystina De Souza Crippa
Objective: The aim of this current report was to present a critical review of the use of cannabidiol (CBD) in the treatment of refractory epilepsies in the pediatric population. Data source: Literature review was carried out in the Medline (PubMed), Cochrane, and Scientific Electronic Library Online (SciELO) databases with the descriptors “Cannabidiol” and “Epilepsy.” The search was not limited by the date of publication, language, or study design. A total of 69 articles were included in the review. Data synthesis: The efficacy of CBD in treating epileptic seizures has been confirmed by randomized controlled trials for Lennox–Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. The incidence of side effects reported in subjects of the studies is high. However, most studies indicate a good safety profile and tolerance to the drug, with most of the adverse effects being mild to moderate and transient. Conclusions: There is no consensus on the release of CBD as a therapeutic tool by the drug regulatory agencies worldwide. However, the use of CBD is promising since it has presented satisfactory results in crisis control in well-designed studies. In addition, this drug has a good safety and tolerance profile. However, further studies with a long follow-up period are needed to confirm its usefulness and the long-term safety in pediatric patients.

19 February 2021 in International Archives of Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
NBNadja Cristina Furtado Back
Nadja Cristina Furtado Back
ACAna Chrystina de Souza Crippa
Ana Chrystina de Souza Crippa
TRTatiana Izabelle Jaworski de Sá Riechi
Tatiana Izabelle Jaworski de Sá Riechi
LPLiliane Desgualdo Pereira
Liliane Desgualdo Pereira
Introduction Nowadays, there is no consensus on whether central auditory processing disorder is a primary or a secondary deficit to other cognitive deficits. A better understanding of the association between cognitive functions and central auditory skills may help elucidate this dilemma. Objective To investigate possible associations between auditory abilities and cognitive functions in schoolchildren. Methods Fifty-eight schoolchildren, aged between 8 years and 0 months old and 11 years and 11 months old, who underwent the following tests: masking level difference, gaps in noise, pitch pattern sequence test, dichotic digits test, sustained auditory attention ability test, Wechsler intelligence scale for children – IV, junior Hayling test, five digits test, and behavior rating inventory of executive function. Results Significant correlations were found between the hearing ability of temporal resolution and executive functions, temporal ordering/sequencing, binaural integration and separation, and sustained auditory attention, operational memory, inhibitory control, and cognitive flexibility; binaural integration was also associated with intelligence. The statistically significant positive correlation found between the ability of binaural interaction and the components of emotional control and behavior regulation of the behavior rating inventory of executive function was unexpected. Conclusion The associations identified reinforce the complexity of the tasks involved in the evaluation of central auditory processing and the need for multidisciplinary evaluation for the differential diagnosis of auditory processing disorder. Confirmation of the presence or absence of comorbidities between different disorders allows directing the therapeutic behaviors and reducing the impact of possible auditory and/or cognitive deficits in the different daily life situations of children.

30 November 2023 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
BBBeatriz Elizabeth Bagatin Veleda Bermudez
Beatriz Elizabeth Bagatin Veleda Bermudez
GFGustavo Leite Franklin
Gustavo Leite Franklin
COCamila Maciel de Oliveira
Camila Maciel de Oliveira
LCLéo Coutinho
Léo Coutinho
ACAna Chrystina de Souza Crippa
Ana Chrystina de Souza Crippa
Background Down syndrome is the most commonly genetic cause of developmental delay and intellectual disability, affecting 1:700 live births. It is associated with heart disease and recurrent infections, among other complications that greatly impair the patient's quality of life. Objective To evaluate the major factors associated with quality of life in a cohort of patients with Down syndrome. Methods We assessed 1,187 patients with Down syndrome, older than 4 years old, with an adaptation of the Personal Outcomes Scale validated for Portuguese language, interviewing patients, parents, and caregivers. Results A bad quality of life was reported in 56.4% of the sample. The main factors associated with better quality of life were female sex, first medical visit before 4 months old, higher parental education, a professionally active mother, and prenatal care. The main factors associated with worse quality of life were family history of alcohol abuse and psychiatric disorders and comorbidity with autism and epilepsy. Conclusion Clinical comorbidities such as autism and epilepsy carry a heavy burden among patients with Down syndrome, while factors related to family support, such as employment status and educational background of the parents, enhance quality of life. The factors associated with quality of life among patients with Down syndrome should be adequately evaluated in medical consultation and targeted in public health policies.

23 February 2024 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
MAMarcela Almeida
Marcela Almeida
SMSuzane Mello
Suzane Mello
MZMarise Bueno Zonta
Marise Bueno Zonta
ACAna Chrystina Crippa
Ana Chrystina Crippa
Background Children with cerebral palsy have a higher prevalence of sleep disorders, with numerous factors associated with a negative impact on the quality of life of caregivers. Objective To identify factors related to sleep disorders, nonpharmacological treatment, and the impact on the lives of caregivers. Methods The present literature review was carried out in the Latin American and Caribbean Center on Health Sciences Information (BIREME), the Cochrane Library, Scopus, PubMed, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycInfo, WorldCat, Web of Science, Latin American Literature on Health Sciences (LILACS), and Excerpta Medica Database (EMBASE), with the descriptors sleep, child, cerebral palsy, parents, and nursing. Studies available in Portuguese, English, or Spanish, published between 2010 and 2020, were our inclusion criteria. A total of 29 articles were included in the present review. Results We considered nonpharmacological interventions effective support measures to drug-based treatments. The main sleep disorders in children with cerebral palsy are insomnia, parasomnias, nightmares, sleep bruxism, sleepwalking, sleep talking, disorders of initiation and maintenance of sleep, and sleep hyperhidrosis. Most studies point to a reduction in the quality of life of caregivers whose children have sleep disorders. Conclusion Our review suggests the effectiveness of nonpharmacological treatments combined with the use of medications. Measures such as changes in sleep environment and routine are favorable strategies to improve sleep quality. In addition, children with sleep disorders negatively impact the quality of life of their caregivers.

1 January 2025 in Revista Paulista de Pediatria
Verified
Journal Article
Open access
PDF file
PMPaloma Alves Miquilussi
Paloma Alves Miquilussi
TAThalis Vasconcellos de Aguiar
Thalis Vasconcellos de Aguiar
PCPaula Lima da Cruz
Paula Lima da Cruz
ADAna Paula Duca
Ana Paula Duca
MRMarcos Ribeiro
Marcos Ribeiro
ACAna Chrystina de Souza Crippa
Ana Chrystina de Souza Crippa
Objective: The objective of this study was to investigate the impact of intrauterine exposure to SARS-CoV-2 on neurodevelopment in children up to 2 years of age.

23 April 2024 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
BNBeatriz Azevedo Nunes
Beatriz Azevedo Nunes
ARAna Karolina Ferreira Gonçalves Romano
Ana Karolina Ferreira Gonçalves Romano
MMMariana Aparecida Pasa Morgan
Mariana Aparecida Pasa Morgan
AGAlice Andrade Gonçalves
Alice Andrade Gonçalves
LCLaís Cardozo
Laís Cardozo
KAKerstin Taniguchi TANIGUCHI ABAGGE
Kerstin Taniguchi TANIGUCHI ABAGGE
Tuberous sclerosis complex (TSC) is a multisystem neurocutaneous syndrome with variable phenotypes. Recent updates of TSC diagnostic criteria reaffirmed the defined genetic diagnostic criterion as the finding of a pathogenic DNA alteration in either TSC1 or TSC2 genes. It also slightly modified definite clinical diagnostic criteria. TSC-associated skin lesions in infancy are important clinical signs to select individuals with possible TSC for a closer clinical follow-up and genetic testing. To raise awareness of the updated TSC diagnosis criteria; to assess the frequency of skin lesions in TSC patients as well as the first dermatological presentation; and to associate the findings with either TSC1 or TSC2 mutations. Observational cross-sectional study. Clinical and genetic data were retrospectively collected from 37 TSC patients from a Brazilian University Hospital. Patients with skin signs were examined and prospectively assessed for 12 months. The earliest cutaneous lesions were hypomelanotic macules, which together with angiofibromas were the most frequent dermatological lesions. The total pathogenic DNA alteration ratio between TSC2 and TSC1 genes was 8:1. The frequency of a TSC2 pathogenic variant was 10-fold greater in the presence of ungual fibromas. Small sample and a limited number of patients with TSC1 pathogenic variants. Clinicians should be knowledgeable about TSC updated diagnostic criteria. Patients need to be followed up by a multidisciplinary team and treated accordingly. Early detection of cutaneous lesions is important for TSC diagnosis. A significant association between TSC2 gene pathogenic alterations and ungual fibromas is described.